Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Elisabet
Elisabet Andersson, Stockholm SE
| Patent application number | Description | Published |
|---|---|---|
| 20080311091 | Engineered Dopamine Neurons and Uses Thereof - The invention relates to dopamine neuron determinants, the use of these determinants in differentiating cells to dopamine neurons, cells produced by the over-expression of these determinants, and uses of these cells. | 12-18-2008 |
Elisabet Ars Criach, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20100086932 | BLADDER CANCER DIAGNOSIS AND/OR PROGNOSIS METHOD - The present invention relates to an in vitro non-invasive bladder cancer diagnosis and/or prognosis method based on the detection and quantification in bladder fluids of the gene expression of certain genes and/or combinations thereof acting as genetic markers of said disease. A bladder cancer diagnosis and/or prognosis kit based on the use of a set of probes suitable for the detection and quantification of the expression pattern of said genes is also contemplated. | 04-08-2010 |
Elisabet Borda Casas, Cardedeu ES
| Patent application number | Description | Published |
|---|---|---|
| 20110213020 | IMMUNOSTIMULANT COMPOSITIONS COMPRISING A NUCLEOBASE AND A POLYSACCHARIDE OBTAINABLE FROM FUNGI, YEAST OR BACTERIA - The present invention relates to compositions comprising nucleobases and/or sources of nucleobases and polysaccharides from extracts of fungi, yeasts or bacteria. Preferably, the compositions include Nucleoforce® or Nucleoforce® Dogs and AHCC®. Said compositions are useful in the treatment and prevention of immunosuppression, of the toxicity derived from chemotherapy or radiotherapy treatment, of diseases of the immune system, of cancer or an infection; and are also useful to stimulate the immune function in a mammal, including a human. | 09-01-2011 |
Elisabet De Los Pinos, Brookline, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20120015899 | MODIFIED PLANT VIRUS PARTICLES AND USES THEREFOR - Aspects of the invention provide modified virus-like particles that are designed for therapeutic applications. In particular, aspects of the invention provide CCMV coat proteins that are modified to generate virus-like particles, including mosaic virus-like particles, that can package and/or deliver one or more diagnostic and/or therapeutic agents. The invention also provides methods for treating subjects with one or more modified virus-like particles. | 01-19-2012 |
Elisabet Graupera, Sabadell ES
| Patent application number | Description | Published |
|---|---|---|
| 20100216926 | Use of Glycerol Acetals - Disclosed is the use of glycerol acetals as coalescent agents and/or solvents for making lacquers and paints. | 08-26-2010 |
Elisabet Helmerson, Billdal SE
| Patent application number | Description | Published |
|---|---|---|
| 20080311007 | PRESSURE EQUALIZING DEVICE, RECEPTACLE AND METHOD - Pressure equalizing device comprising a fluid container for attachment to a receptacle such as a vial to permit pressure equalization between the fluid container and the receptacle. The pressure equalizing device comprises a flow channel that is arranged to provide fluid communication into or out of the fluid container when the pressure equalizing device is attached to the receptacle. The pressure equalizing device also comprises a fluid inlet that contains a one-way valve that permits fluid to flow into the fluid container via said fluid inlet and that prevents fluid from flowing out of the fluid container via said fluid inlet and filter-receiving means that are arranged to permit fluid flowing into or out of the fluid container to be filtered when the filter-receiving means comprises a filter. | 12-18-2008 |
| 20080312634 | DEVICE FOR PROVIDING FLUID TO A RECEPTACLE - A device for providing sterilized or cleaned fluid to a receptacle and thereby facilitate conveyance of a substance out of the receptacle, comprising a connector and a container which form an integrated unit. The connector is provided with a first means for connection to a receptacle. Sterilized or cleaned fluid is transferred from the container to the receptacle. | 12-18-2008 |
Elisabet Jerlhag, Goteborg SE
| Patent application number | Description | Published |
|---|---|---|
| 20100093638 | TREAMENT FOR CHEMICAL SUBSTANCE ADDICTION - The present invention provides a method for the treatment of chemical substance abuse by selectively inhibiting ghrelin activity in humans comprising administering to a human in need thereof a therapeutically-effective amount of a ghrelin receptor ligand (GHS-RL). The ghrelin receptor ligand (GHS-RL) can be selected from the group consisting of a ghrelin receptor antagonist (GHS-RA), a ghrelin receptor inverse agonist (GHS-RIA), and a ghrelin receptor partial agonist (GHS-RPA). More specifically, the invention provides a method for treating alcohol related disorders in humans comprising administering to a human in need thereof a therapeutically-effective amount of a compound which is a ghrelin receptor ligand (GHS-RL), such as a ghrelin receptor antagonist (GHS-RA), a ghrelin receptor inverse agonist (GHS-RIA) and a ghrelin receptor partial agonist (GHS-RPA). | 04-15-2010 |
Elisabet Monita Castro US
| Patent application number | Description | Published |
|---|---|---|
| 20090326953 | Method of accessing cultural resources or digital contents, such as text, video, audio and web pages by voice recognition with any type of programmable device without the use of the hands or any physical apparatus. - The use of voice as a means of communication with a computer or programmable device ( | 12-31-2009 |
Elisabet Wallgard, Goteborg SE
| Patent application number | Description | Published |
|---|---|---|
| 20090036362 | Angiogenesis Affecting Polypeptides, Proteins, and Composition, and Methods of Use Thereof - The present invention relates to polynucleotides and proteins associated with vasculogenesis- and angiogenesis-related disorders. The invention further relates to methods for the identification of compounds that modulate the expression of angiogenesis-related genes and gene products and to using such compounds as therapeutic agents in the treatment of angiogenesis-related disorders. The invention also relates to methods for the diagnostic evaluation, genetic testing and prognosis of angiogenesis-related disorders, and to methods and compositions for the treatment these disorders. | 02-05-2009 |
Elisabet Wallgard, Huskvarna SE
| Patent application number | Description | Published |
|---|---|---|
| 20090209473 | Componds and methods for pormoting angiogenesis - Angiogenesis may be initiated or increased through the use of gamma-secretase inhibitors. The gamma-secretase inhibitor can be a dipeptide class, sulfonamide class, transition state mimic class, benzodiazepine class, or benzocaprolactam class gamma secretase inhibitor. Methods for initiating and increasing angiogenesis are used for disease prevention and treatment as well as for generating research models. | 08-20-2009 |